Inhibition of 12-O-tetradecanoyl-phorbol-13-acetate-induced tumor promotion by nordihydroguaiaretic acid, a lipoxygenase inhibitor, and p-bromophenacyl bromide, a phospholipase A2 inhibitor.
D000098:Acetophenones / Q000494:pharmacology*; D000818:Animals; D002396:Catechols / Q000494:pharmacology*; D004791:Enzyme Inhibitors; D005260:Female; D016859:Lipoxygenase Inhibitors; D009637:Masoprocol; D051379:Mice; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000139:chemically induced; D010704:Phorbols; D010740:Phospholipases / Q000037:antagonists & inhibitors*; D010741:Phospholipases A / Q000037:antagonists & inhibitors*; D054467:Phospholipases A2; D011720:Pyrazoles / Q000494:pharmacology; D012878:Skin Neoplasms / Q000139:chemically induced*; D013755:Tetradecanoylphorbol Acetate; D013997:Time Factors
D000098:Acetophenones; D002396:Catechols; D004791:Enzyme Inhibitors; D016859:Lipoxygenase Inhibitors; D010704:Phorbols; D011720:Pyrazoles; D009637:Masoprocol; D010740:Phospholipases; D010741:Phospholipases A; D054467:Phospholipases A2; C015429:phenidone; D013755:Tetradecanoylphorbol Acetate; C006821:4-bromophenacyl bromide